The Bioinformatics CRO Podcast

Fernando Martinez, senior scientist at Fountain Therapeutics, uses AI and phenotypic screening to discover drugs that reduce the signs of aging.

The Bioinformatics CRO is a fully distributed contract…

Jeremy Kamil, associate professor of microbiology at LSU Health Shreveport, discusses the genetics of SARS-CoV-2, variants, and vaccines with guest host Razib Khan.

The Bioinformatics CRO is a fully …

Adam Robertson, CSO of Hemispherian, talks about developing cancer therapeutics in an Oslo-based startup.

The Bioinformatics CRO is a fully distributed contract research company that serves the compu…

Brett Abrahams, Executive VP of R&D at Magnolia Neurosciences, discusses his work on chemotherapy-induced peripheral neuropathy and other brain disorders.

The Bioinformatics CRO is a fully distribute…

We spoke with Noor Siddiqui about how Orchid is using polygenic risk scores for common diseases for preimplantation screening.

The Bioinformatics CRO is a fully distributed contract research company …

Matthew Holt, neuroscience professor at VIB-KU Leuven, explains the role of glial cells in neurodegenerative diseases and discusses boxing and motorbike racing.

The Bioinformatics CRO is a fully dist…

Lucia and Jimmy, co-founders of Osmind, discuss psychedelic therapies for mental illness, the future of the Bay Area, and public benefit corporations.

The Bioinformatics CRO is a fully distributed co…

Our regular host, Grant Belgard, founder of The Bioinformatics CRO, talks about his career working remotely and how he expects technology to change the biotech industry.

The Bioinformatics CRO is a f…

We talk with Ambika Bumb, science and technology advisor to the department of state’s crisis management and strategy team, about nanotechnology, the pandemic, and biotech start-ups.

The Bioinformatic…

We talk with Lucas Steuber, clinical product and marketing director at Cognixion, about using a brain-computer interface and augmented reality to help people with speech disabilities communicate.

The…

We talk with Trevor Martin, co-founder and CEO of Mammoth Biosciences, about using CRISPR technology to detect SARS-CoV-2, his experience as a new CEO, and science education.

The Bioinformatics CRO i…

Dan Geschwind, professor and associate vice chancellor at UCLA, shares his path to neuroscience, thoughts on precision medicine, and why one should use unbiased methods to prioritize hypotheses.

The …

In our first panel discussion, three COVID experts share their thoughts on emerging variants of SARS-CoV-2 and the growing selective pressures for immune escape.

The Bioinformatics CRO is a fully dis…

Delian Asparouhov, co-founder of Varda Space Industries and principal at Founders Fund, talks about space manufacturing, economic bubbles, and tech investing.

The Bioinformatics CRO is a fully dist…

We chat with Vay Cao, founder of Free the PhD, about her journey from neuroscience to an MSL-like role and how PhDs can leverage their experiences to get that first job outside academia.

The Bioinfor…

We talk with Mark DePristo, founder and CEO of BigHat Biosciences, about building better antibody therapeutics using machine learning, overcoming the fear of failure, and the pros and cons of working…

We talk with Shaan Gandhi, Director at Northpond Ventures, about the intersections of science, medicine, and business and how his training as an internist has colored his experience in venture capita…

We talk with Peter Joyce, co-founder and CEO of Grey Wolf Therapeutics, about novel cancer therapies, running a virtual biotech company, and encouraging a new generation of well-rounded scientists. (…

We talk with Adam Marblestone about his work with moonshot science and technology projects, exciting advances in nanotechnology and AI, and his PhD work using expansion microscopy to map neural conne…

We speak with C. Anthony Altar, PhD, president and COO of Splice Therapeutics, about his successful career in neuropharmacology and his role in pioneering the sport of skateboarding in the 1960's. (R…